Infimer Stock Profit Margin
| INFR-M Stock | 14.60 14.50 14,500% |
Infimer fundamentals help investors to digest information that contributes to Infimer's financial success or failures. It also enables traders to predict the movement of Infimer Stock. The fundamental analysis module provides a way to measure Infimer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infimer stock.
Infimer |
Infimer Company Profit Margin Analysis
Infimer's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Infimer has a Profit Margin of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Profit Margin (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Infimer Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infimer's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infimer could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics of similar companies.Infimer is currently under evaluation in profit margin category among its peers.
Infimer Fundamentals
| Return On Asset | 0.49 | |||
| Shares Owned By Insiders | 6.64 % | |||
| Shares Owned By Institutions | 10.03 % | |||
| Revenue | 350 K | |||
| Gross Profit | (401 K) | |||
| EBITDA | 1.5 M | |||
| Book Value Per Share | (4.63) X | |||
| Earnings Per Share | (0.59) X | |||
| Beta | 1.62 |
About Infimer Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infimer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infimer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infimer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.